Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 44.00
+0.30 (0.69%)
Dec 26, 2025, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 3.82 billion as of December 26, 2025. Its market cap has decreased by -9.65% in one year.
Market Cap
3.82B
Enterprise Value
5.65B
Revenue
4.53B
Ranking
n/a
PE Ratio
n/a
Stock Price
44.00
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 3.82B, an increase of 444.64%. That is a compound annual growth rate of 8.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 3.82B | -8.71% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | 4.17B | -13.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 250.47B |
| PharmaEssentia | 181.23B |
| Heron Neutron Medical | 75.90B |
| Lotus Pharmaceutical | 73.24B |
| Bora Pharmaceuticals Co., LTD. | 61.70B |
| Lin BioScience | 32.76B |
| Lumosa Therapeutics | 32.09B |
| Center Laboratories | 27.70B |